REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 202 filers reported holding REPLIGEN CORP in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $391,000 | -13.7% | 9,427 | -35.8% | 0.02% | -54.1% |
Q4 2016 | $453,000 | -42.3% | 14,695 | -49.8% | 0.04% | -31.5% |
Q1 2016 | $785,000 | +66.0% | 29,257 | +72.3% | 0.05% | +92.9% |
Q3 2015 | $473,000 | -54.5% | 16,984 | -50.4% | 0.03% | -56.2% |
Q1 2015 | $1,040,000 | +402.4% | 34,269 | +229.1% | 0.06% | +357.1% |
Q3 2014 | $207,000 | – | 10,413 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |